Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Osteoarthritis Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
The global osteoarthritis therapeutics market grew at a CAGR of around 8% during 2014-2019.
Osteoarthritis (OA) is a heterogeneous condition characterized by progressive degeneration of cartilage in joints of the knees, hips, hands, feet, spine, shoulders and neck. OA generally leads to stiffness, swelling, tenderness, persistent pain, loss of flexibility, grating sensation, bone spurs and sleep disturbances. It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan.
Various medications and surgical procedures are prescribed as per the different results to alleviate the signs and symptoms of the disease. Currently, alternative medicines, physical therapies and supportive devices are available in the market to relieve pain and improve joint function.
Sedentary lifestyles, unhealthy dietary patterns and the rising prevalence of obesity and blood sugar are increasing the risk of developing OA among individuals. This, in confluence with the growing geriatric population, which is more susceptible to such ailments, represents one of the key factors impelling the market growth.
Apart from this, the easy access to MRI scans is acting as another major growth-inducing factor. Additionally, the development of imaging biomarkers based on radiographic features, coupled with the introduction of analgesic drugs, is contributing to the market growth.
Furthermore, rising investments in the research and development (R&D) activities to launch new diagnostics and biomarkers, along with the increasing expenditures on improving healthcare infrastructure, is also driving the market. For instance, disease-modifying drugs are under development, which focus on proinflammatory cytokines for treating cartilage breakdown.
Looking forward, the publisher expects the global osteoarthritis therapeutics market to continue its moderate growth during the next five years.
Key Questions Answered in This Report:
- How has the global osteoarthritis therapeutics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global osteoarthritis therapeutics market?
- What are the key regional markets?
- What is the breakup of the market based on the anatomy type?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the route of administration?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global osteoarthritis therapeutics market and who are the key players?
- What is the degree of competition in the industry?
Key Market Segmentation:
Breakup by Anatomy Type:
- Knee
- Hip
- Hand
- Spine
- Others
Breakup by Drug Type:
- Nonsteroidal Anti-Inflammatory Drugs
- Analgesics
- Corticosteroids
- Others
Breakup by Route of Administration:
- Parenteral
- Topical
- Oral
Breakup by End User:
- Hospitals
- Specialty Clinics
- Medical Institutions
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Companies Mentioned
- Abbott Laboratories
- Anika Therapeutics Inc.
- Bayer Aktiengesellschaft
- Eli Lilly
- Company
- Flexion Therapeutics Inc.
- GlaxoSmithKline Plc
- Horizon Therapeutics Plc
- Johnson & Johnson Inc.
- Pfizer Inc.
- Sanofi S.A
For more information about this report visit https://www.researchandmarkets.com/r/ffqctu
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.